Ferrer

  • Patients
  • Healthcare professionals
  • Ethical channel
  • Join us
  • News
  • Contact
EN

Navegación principal

  • We are Ferrer
    • Ferrer for good
    • Annual reports
    • Ethics and compliance
    • Transparency
    • Management team
    • Our history
  • Great People
  • Liveable Planet
  • Collective Action
  • Science
    • R&D Strategy
    • Pipeline
    • Our technologies
    • Clinical trials
    • Expanded Access Programs
  • Our Activities
    • A global presence
    • Pharmaceuticals
    • Active ingredients (APIs)
    • Business development
    • Manufacturing and distribution
EnglishEspañolCatalàNederlandsPortuguês, PortugalČeštinaFrançaisDeutschPolski

News

All of Ferrer’s information, just a click away

  1. Home
  2. News
normal

Ferrer announces distribution agreement with United Therapeutics for treprostinil inhalation solution for pulmonary hypertension associated with interstitial lung disease

.
Wed, 02/23/2022 - 15:24

Ferrer becomes a B Corp for its positive impact in society

.
Tue, 01/25/2022 - 15:06

Ferrer joins Barcelona + B, a project to bring the business community closer to the SDGs

.
Mon, 11/29/2021 - 17:47

First patient enrolled in Ferrer's FNP122 ADORE Phase III clinical trial for Amyotrophic Lateral Sclerosis (ALS) treatment

.
Mon, 11/08/2021 - 14:12

World Stroke Day - "Another one?" campaign

.
Fri, 10/29/2021 - 06:53

Ferrer signs license agreement to develop an oral formulation treatment for patients with ALS

.
Wed, 10/20/2021 - 09:29

The Ferrer team let loose their activism in the first Days for Good

.
Fri, 10/08/2021 - 09:47

Ferrer launches third edition of Ferrer 4 Future program

.
Tue, 07/06/2021 - 06:31

Ferrer certified as a great place to work, with people at the center of its cultural transformation

.
Fri, 06/25/2021 - 12:57

Ferrer’s new headquarters in Barcelona

.
Fri, 06/25/2021 - 12:56
  • Cargar más
For requests for interviews or information, please contact the Communications Department

CONTACT US

alternatively, please dial +34 936 003 779

See more

R&D Strategy
Business Development

Connect

  • Contact
  • Join us
  • Press

B corp

Redes sociales footer

  • Facebook
  • linkedin
  • Youtube
  • Instagram
  • Twitter

European Union - European Regional Development Fund (ERDF)

Legal footer

  • Legal Notice
  • Privacy policy
  • Cookies policy

© 2025 Copyright Grupo Ferrer Internacional, S.A. All rights reserved.

Según la legislación vigente la información que precisa ver se considera información dirigida exclusivamente al profesional sanitario.

¿Es usted profesional sanitario?